FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

AVEVA Drug Delivery Systems Nicotine Transdermal System Patch Recall

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RU…

AVEVA Drug Delivery Systems, Inc. · Miramar, FL

Risk level
Class III
Reported by FDA
Jun 3, 2026
Recall ID
D-0550-2026
Check your lot numberHow we source this data

Summary

AVEVA Drug Delivery Systems recalled Nicotine Transdermal System Patch starting May 14, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0550-2026 on Jun 3, 2026. Reason: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Product description

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.

Lot numbers, UPCs & expiration codes

Lot #: 56841, Expires: 03/2028

Where it was sold

Nationwide within the U.S

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0550-2026
Classification
Class III
Status
Ongoing
Recall initiated
May 14, 2026
FDA report date
Jun 3, 2026
Quantity
59,808 pouches (4,272 Individual Folding Carton (IFC))
Recall type
Voluntary: Firm initiated
Recalling firm
AVEVA Drug Delivery Systems, Inc.

Original FDA data

Every field from FDA enforcement report D-0550-2026, exactly as published.

Show all FDA fields
City
Miramar
State
FL
Status
Ongoing
Country
United States
Event ID
98972
Address
3250 Commerce Pkwy
Code information
Lot #: 56841, Expires: 03/2028
Postal code
33025-3907
Report date
Jun 3, 2026
Product type
Drugs
Recall number
D-0550-2026
Classification
Class III
Recalling firm
AVEVA Drug Delivery Systems, Inc.
Product quantity
59,808 pouches (4,272 Individual Folding Carton (IFC))
Reason for recall
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.
Distribution pattern
Nationwide within the U.S
Recall initiation date
May 14, 2026
Initial firm notification
Letter
Center classification date
May 26, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0550-2026, published Jun 3, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls